Concepedia

Hugh Kawabata

HK

Statistics

Publications

17

Citations

1.3K

H-Index

15

Active since

2002

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Pfizer (United States)

Brigham and Women's Hospital

Harvard University

Hugh Kawabata is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacotherapy, and internal medicine.

Publications per year

2002–2020

17

Publications

17

Coronary Heart Disease in HIV-Infected Individuals

Judith S. Currier, Anne Taylor, Felicity Boyd et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 536 citations

, , +17

Effects of Once-Daily and Twice-Daily Dosing on Adherence With Prescribed Glipizide Oral Therapy for Type 2 Diabetes

Christopher M. Dezii, Hugh Kawabata, Michelle Tran · Southern Medical Journal · 2002 · 130 citations

, , +16

Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States

Gregory Y.H. Lip, Xianying Pan, Shital Kamble et al. · International Journal of Clinical Practice · 2016 · 105 citations · Full text

, , +15

Association Between Hypoglycemia and Fall-Related Events in Type 2 Diabetes Mellitus: Analysis of a U.S. Commercial Database

Sumesh Kachroo, Hugh Kawabata, Susan Colilla et al. · Journal of Managed Care & Specialty Pharmacy · 2015 · 76 citations · Full text

, , +16

Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban

Gregory Y.H. Lip, Xianying Pan, Shital Kamble et al. · PLoS ONE · 2018 · 56 citations · Full text

, , +16

1–5 of 17